Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYThe Turkish Journal of Pediatrics

Perineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle

Abstract

Background. Congenital disorders of glycosylation (CDG) represent a group of inherited metabolic diseases characterized by multisystem involvement. SLC35A2-CDG (OMIM #300896) is a rare X-linked subtype resulting from pathogenic variants in the SLC35A2 gene, which encodes the UDP-galactose transporter. Approximately 70 cases have been documented, predominantly presenting with early-onset epilepsy, developmental delay, hypotonia, and dysmorphic features. Phenotypic variability remains incompletely characterized, and novel features continue to expand the clinical spectrum.

Case Presentation. We report a 6-year-old girl with SLC35A2-CDG harboring a novel de novo heterozygous frameshift variant (NM_005660.3: c.105_106insCG, p.K36Rfs*6). The patient presented with epileptic spasms, severe global developmental delay, hypotonia, and distinctive dysmorphic features including strabismus and inverted nipples. Notably, she exhibited bilateral patellar luxation and perineal dysmorphism with a shortened anogenital distance, features that have not been previously associated with SLC35A2-CDG. Additional findings included a thin corpus callosum, a pineal cyst, right-sided aortic arch, bilateral vesicoureteral reflux, and central hypothyroidism. Oral D-galactose supplementation was initiated and resulted in subjective improvements in language comprehension, pain responsiveness, and motor function, although no improvement in seizures was observed.

Conclusions. This casa may expand the phenotypic spectrum of SLC35A2-CDG by describing bilateral patellar luxation and perineal dysmorphism as potentially novel clinical features, along with a previously unreported pathogenic variant. Recognition of such unique features is crucial for improving our clinical understanding of this rare disorder, guiding differential diagnosis, and contributing to a more refined characterization of genotype–phenotype correlations.

Related

  1. Chondroprotective Effect of PCSO‐524 (Green‐Lipped Mussel Extraction) Application Evaluated by Ultrasonography in Pomeranian and Chihuahua With Medial Patellar Luxation Grade II
    Kumpanart Soontornvipart, Ratthanan Sathienbumrungkit
    Veterinary Medicine and SciencePeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  2. Longitudinal analysis of clinical and biochemical outcomes during seven years of galactose supplementation in a patient with SLC35A2-CDG.
    Yupeng Liu, Earnest J P Daniel, Wenyue Zhang +2
    Molecular genetics and metabolism reportsPeer-reviewedCC BY-NC-NDFull textPhysiologyEurope PMC
  3. Surgical Approaches to Perineal Reconstruction: A Narrative Review
    David A Febre-Alemañy, Michael J Franco
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Comments on "Mini-invasive J-colpo-perineo-rectopexy with titanized polypropylene mesh for global perineal descent: a technical note".
    Alaa Abood Al Wadees
    Annals of coloproctologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Bladder Urothelial Carcinoma Diagnosed by Perineal Cutaneous Biopsy: A Case Report
    Ramon J Guiu, Guilherme C Dias, Pedro H Silva +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{gok2026perineal,
  title = {{Perineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle}},
  author = {Anıl Gök and Tolgahan Özer and Özlem Akgün Doğan and Mehmet Cihan Balcı and Filiz Çizmecioğlu Jones and Bülent Kara and Yasemin Alanay},
  journal = {The Turkish Journal of Pediatrics},
  year = {2026},
  month = oct,
  doi = {10.24953/turkjpediatr.2026.8349},
  url = {https://doi.org/10.24953/turkjpediatr.2026.8349},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Perineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle
AU  - Anıl Gök
AU  - Tolgahan Özer
AU  - Özlem Akgün Doğan
AU  - Mehmet Cihan Balcı
AU  - Filiz Çizmecioğlu Jones
AU  - Bülent Kara
AU  - Yasemin Alanay
PY  - 2026
DA  - 2026/10/25
JO  - The Turkish Journal of Pediatrics
DO  - 10.24953/turkjpediatr.2026.8349
UR  - https://doi.org/10.24953/turkjpediatr.2026.8349
AB  - Background. Congenital disorders of glycosylation (CDG) represent a group of inherited metabolic diseases characterized by multisystem involvement. SLC35A2-CDG (OMIM #300896) is a rare X-linked subtype resulting from pathogenic variants in the SLC35A2 gene, which encodes the UDP-galactose transporter. Approximately 70 cases have been documented, predominantly presenting with early-onset epilepsy, developmental delay, hypotonia, and dysmorphic features. Phenotypic variability remains incompletely characterized, and novel features continue to expand the clinical spectrum.  Case Presentation. We report a 6-year-old girl with SLC35A2-CDG harboring a novel de novo heterozygous frameshift variant (NM_005660.3: c.105_106insCG, p.K36Rfs*6). The patient presented with epileptic spasms, severe global developmental delay, hypotonia, and distinctive dysmorphic features including strabismus and inverted nipples. Notably, she exhibited bilateral patellar luxation and perineal dysmorphism with a shortened anogenital distance, features that have not been previously associated with SLC35A2-CDG. Additional findings included a thin corpus callosum, a pineal cyst, right-sided aortic arch, bilateral vesicoureteral reflux, and central hypothyroidism. Oral D-galactose supplementation was initiated and resulted in subjective improvements in language comprehension, pain responsiveness, and motor function, although no improvement in seizures was observed.  Conclusions. This casa may expand the phenotypic spectrum of SLC35A2-CDG by describing bilateral patellar luxation and perineal dysmorphism as potentially novel clinical features, along with a previously unreported pathogenic variant. Recognition of such unique features is crucial for improving our clinical understanding of this rare disorder, guiding differential diagnosis, and contributing to a more refined characterization of genotype–phenotype correlations.
SN  - 0041-4301
SN  - 2791-6421
ER  -